-
-
A 2009 influenza a (h1n1) vaccine was evaluated in a large randomized placebo controlled study in China. The immunization schedule consisted of two doses administered 21 days apart.
-
Until recently, the literature has offered little direction on how to manage patients who have short cervices in the second trimester.
-
In this issue: Efficacy of once-daily insulin, aldo-sterone use in heart failure, erectile dysfunction Clinical Practice Guidelines, and FDA Actions.
-
Good news for patients at your clinic: The second-generation FC2 Female Condom is available for purchase in the United States, which gives American women a nonlatex, female-controlled option in disease protection.
-
Women in the United States now account for more than one-quarter of all new HIV/AIDS diagnoses.
-
Update your clinical practice; make your plans now for the following 2010 conferences:
-
Check the records of women who are scheduled to return to your facility for a contraceptive refill or annual well woman exam. Are you seeing empty spots in the schedule?
-
Two new actions from the Food and Drug Administration (FDA) will impact your practice.
-
Clinicians now have an approved indication in hand for use of the levonorgestrel intrauterine system Mirena (LNG IUS, Mirena, Bayer HealthCare Pharmaceuticals; Wayne, NJ), to treat heavy menstrual bleeding in women who use intrauterine contraception as their method of pregnancy prevention.
